Figure 3
Forest plots of most important secondary outcomes. (A) Relative risk of ablation-associated persistent phrenic nerve palsy in randomized and non-randomized studies. Test for subgroup differences: Z = −0.627 (P = 0.531). Overall heterogeneity: I2 = 0.00%. (B) Difference between double freeze and single freeze procedure duration in randomized and non-randomized studies (presented in minutes). Test for subgroup differences: Z = 1.957 (P = 0.050). Overall heterogeneity: I2 = 95.72%. 95% CI, 95% confidence interval; RCT, randomized clinical trial; RR, relative risk.

Forest plots of most important secondary outcomes. (A) Relative risk of ablation-associated persistent phrenic nerve palsy in randomized and non-randomized studies. Test for subgroup differences: Z = −0.627 (P = 0.531). Overall heterogeneity: I2 = 0.00%. (B) Difference between double freeze and single freeze procedure duration in randomized and non-randomized studies (presented in minutes). Test for subgroup differences: Z = 1.957 (P = 0.050). Overall heterogeneity: I2 = 95.72%. 95% CI, 95% confidence interval; RCT, randomized clinical trial; RR, relative risk.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close